Clinical Trial

Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The trial investigates a stage-adapted (stage IIA or IIB) de-escalation of the standard treatments in the context of a multimodality treatment with chemo- and radiotherapy in seminoma patients. The goal is to safely de-escalate treatment while maintaining/enhancing efficacy, which is not a standard practice yet.
Protocol Amendment History 18 amendments
This ClinicalTrials.gov record has been amended 18 times since 2019-05-03; most recent amendment 2026-01-16.
Status change: Recruiting → Active, Not Recruiting 2023-06-23
Status change: Not Yet Recruiting → Recruiting 2019-07-11
Trial Details
NCT Number NCT03937843
Lead Sponsor Swiss Cancer Institute
Collaborators: German Testicular Cancer Study Group
Conditions Seminoma, Testicular Cancer
Enrollment 135 participants
Start Date 2019-07-29
Primary Completion 2026-12-31 (estimated)
Study Completion 2046-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-20